nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—Risedronate—PTGS2—pancreatic cancer	0.00277	1	CrCbGaD
Ibandronate—Fatigue—Gemcitabine—pancreatic cancer	0.000722	0.000724	CcSEcCtD
Ibandronate—Gastritis—Epirubicin—pancreatic cancer	0.000721	0.000723	CcSEcCtD
Ibandronate—Pain—Gemcitabine—pancreatic cancer	0.000716	0.000718	CcSEcCtD
Ibandronate—Constipation—Gemcitabine—pancreatic cancer	0.000716	0.000718	CcSEcCtD
Ibandronate—Nausea—Erlotinib—pancreatic cancer	0.000716	0.000718	CcSEcCtD
Ibandronate—Decreased appetite—Fluorouracil—pancreatic cancer	0.000715	0.000717	CcSEcCtD
Ibandronate—Diarrhoea—Sunitinib—pancreatic cancer	0.000714	0.000716	CcSEcCtD
Ibandronate—Dysgeusia—Docetaxel—pancreatic cancer	0.000713	0.000715	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00071	0.000712	CcSEcCtD
Ibandronate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000708	0.00071	CcSEcCtD
Ibandronate—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000707	0.000709	CcSEcCtD
Ibandronate—Influenza—Epirubicin—pancreatic cancer	0.000705	0.000706	CcSEcCtD
Ibandronate—Dysphagia—Epirubicin—pancreatic cancer	0.000705	0.000706	CcSEcCtD
Ibandronate—Asthma—Epirubicin—pancreatic cancer	0.000705	0.000706	CcSEcCtD
Ibandronate—Back pain—Docetaxel—pancreatic cancer	0.000704	0.000706	CcSEcCtD
Ibandronate—Pain—Fluorouracil—pancreatic cancer	0.000704	0.000706	CcSEcCtD
Ibandronate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000703	0.000705	CcSEcCtD
Ibandronate—Muscle spasms—Docetaxel—pancreatic cancer	0.0007	0.000702	CcSEcCtD
Ibandronate—Dizziness—Sunitinib—pancreatic cancer	0.00069	0.000692	CcSEcCtD
Ibandronate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00069	0.000692	CcSEcCtD
Ibandronate—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000689	0.000691	CcSEcCtD
Ibandronate—Breast disorder—Doxorubicin—pancreatic cancer	0.000682	0.000683	CcSEcCtD
Ibandronate—Abdominal pain—Irinotecan—pancreatic cancer	0.000679	0.000681	CcSEcCtD
Ibandronate—Body temperature increased—Irinotecan—pancreatic cancer	0.000679	0.000681	CcSEcCtD
Ibandronate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000678	0.00068	CcSEcCtD
Ibandronate—Bronchitis—Epirubicin—pancreatic cancer	0.000678	0.000679	CcSEcCtD
Ibandronate—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000674	0.000676	CcSEcCtD
Ibandronate—Anaemia—Docetaxel—pancreatic cancer	0.000673	0.000675	CcSEcCtD
Ibandronate—Gastritis—Doxorubicin—pancreatic cancer	0.000667	0.000669	CcSEcCtD
Ibandronate—Vomiting—Sunitinib—pancreatic cancer	0.000663	0.000665	CcSEcCtD
Ibandronate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000662	0.000664	CcSEcCtD
Ibandronate—Rash—Sunitinib—pancreatic cancer	0.000658	0.00066	CcSEcCtD
Ibandronate—Dermatitis—Sunitinib—pancreatic cancer	0.000657	0.000659	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000655	0.000657	CcSEcCtD
Ibandronate—Urticaria—Fluorouracil—pancreatic cancer	0.000654	0.000656	CcSEcCtD
Ibandronate—Headache—Sunitinib—pancreatic cancer	0.000653	0.000655	CcSEcCtD
Ibandronate—Asthma—Doxorubicin—pancreatic cancer	0.000652	0.000654	CcSEcCtD
Ibandronate—Influenza—Doxorubicin—pancreatic cancer	0.000652	0.000654	CcSEcCtD
Ibandronate—Dysphagia—Doxorubicin—pancreatic cancer	0.000652	0.000654	CcSEcCtD
Ibandronate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000651	0.000652	CcSEcCtD
Ibandronate—Palpitations—Docetaxel—pancreatic cancer	0.000643	0.000645	CcSEcCtD
Ibandronate—Weight decreased—Epirubicin—pancreatic cancer	0.000637	0.000639	CcSEcCtD
Ibandronate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000633	0.000635	CcSEcCtD
Ibandronate—Pneumonia—Epirubicin—pancreatic cancer	0.000632	0.000634	CcSEcCtD
Ibandronate—Hypertension—Docetaxel—pancreatic cancer	0.000628	0.00063	CcSEcCtD
Ibandronate—Infestation NOS—Epirubicin—pancreatic cancer	0.000628	0.00063	CcSEcCtD
Ibandronate—Infestation—Epirubicin—pancreatic cancer	0.000628	0.00063	CcSEcCtD
Ibandronate—Bronchitis—Doxorubicin—pancreatic cancer	0.000627	0.000629	CcSEcCtD
Ibandronate—Chest pain—Docetaxel—pancreatic cancer	0.00062	0.000621	CcSEcCtD
Ibandronate—Arthralgia—Docetaxel—pancreatic cancer	0.00062	0.000621	CcSEcCtD
Ibandronate—Myalgia—Docetaxel—pancreatic cancer	0.00062	0.000621	CcSEcCtD
Ibandronate—Nausea—Sunitinib—pancreatic cancer	0.00062	0.000621	CcSEcCtD
Ibandronate—Renal failure—Epirubicin—pancreatic cancer	0.000617	0.000619	CcSEcCtD
Ibandronate—Asthenia—Irinotecan—pancreatic cancer	0.000616	0.000618	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000615	0.000617	CcSEcCtD
Ibandronate—Stomatitis—Epirubicin—pancreatic cancer	0.000612	0.000614	CcSEcCtD
Ibandronate—Urinary tract infection—Epirubicin—pancreatic cancer	0.000611	0.000612	CcSEcCtD
Ibandronate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000606	0.000608	CcSEcCtD
Ibandronate—Dry mouth—Docetaxel—pancreatic cancer	0.000606	0.000608	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000606	0.000608	CcSEcCtD
Ibandronate—Sweating—Epirubicin—pancreatic cancer	0.000602	0.000604	CcSEcCtD
Ibandronate—Asthenia—Gemcitabine—pancreatic cancer	0.000601	0.000602	CcSEcCtD
Ibandronate—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000594	0.000596	CcSEcCtD
Ibandronate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000594	0.000596	CcSEcCtD
Ibandronate—Pruritus—Gemcitabine—pancreatic cancer	0.000592	0.000594	CcSEcCtD
Ibandronate—Infection—Docetaxel—pancreatic cancer	0.00059	0.000592	CcSEcCtD
Ibandronate—Weight decreased—Doxorubicin—pancreatic cancer	0.00059	0.000591	CcSEcCtD
Ibandronate—Diarrhoea—Irinotecan—pancreatic cancer	0.000588	0.00059	CcSEcCtD
Ibandronate—Pneumonia—Doxorubicin—pancreatic cancer	0.000585	0.000586	CcSEcCtD
Ibandronate—Shock—Docetaxel—pancreatic cancer	0.000584	0.000586	CcSEcCtD
Ibandronate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000583	0.000584	CcSEcCtD
Ibandronate—Pruritus—Fluorouracil—pancreatic cancer	0.000582	0.000584	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—pancreatic cancer	0.000581	0.000583	CcSEcCtD
Ibandronate—Infestation—Doxorubicin—pancreatic cancer	0.000581	0.000583	CcSEcCtD
Ibandronate—Skin disorder—Docetaxel—pancreatic cancer	0.000577	0.000579	CcSEcCtD
Ibandronate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000573	0.000574	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—pancreatic cancer	0.000571	0.000573	CcSEcCtD
Ibandronate—Dizziness—Irinotecan—pancreatic cancer	0.000568	0.00057	CcSEcCtD
Ibandronate—Haemoglobin—Epirubicin—pancreatic cancer	0.000567	0.000568	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—pancreatic cancer	0.000567	0.000568	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000565	0.000567	CcSEcCtD
Ibandronate—Haemorrhage—Epirubicin—pancreatic cancer	0.000564	0.000565	CcSEcCtD
Ibandronate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000563	0.000565	CcSEcCtD
Ibandronate—Pharyngitis—Epirubicin—pancreatic cancer	0.00056	0.000561	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—pancreatic cancer	0.000557	0.000559	CcSEcCtD
Ibandronate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000557	0.000558	CcSEcCtD
Ibandronate—Oedema peripheral—Epirubicin—pancreatic cancer	0.000556	0.000557	CcSEcCtD
Ibandronate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000554	0.000556	CcSEcCtD
Ibandronate—Urethral disorder—Epirubicin—pancreatic cancer	0.000553	0.000554	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00055	0.000551	CcSEcCtD
Ibandronate—Vomiting—Irinotecan—pancreatic cancer	0.000546	0.000548	CcSEcCtD
Ibandronate—Dizziness—Fluorouracil—pancreatic cancer	0.000544	0.000546	CcSEcCtD
Ibandronate—Rash—Irinotecan—pancreatic cancer	0.000542	0.000543	CcSEcCtD
Ibandronate—Dermatitis—Irinotecan—pancreatic cancer	0.000541	0.000543	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000541	0.000543	CcSEcCtD
Ibandronate—Headache—Irinotecan—pancreatic cancer	0.000538	0.00054	CcSEcCtD
Ibandronate—Insomnia—Docetaxel—pancreatic cancer	0.000537	0.000539	CcSEcCtD
Ibandronate—Paraesthesia—Docetaxel—pancreatic cancer	0.000533	0.000535	CcSEcCtD
Ibandronate—Vomiting—Gemcitabine—pancreatic cancer	0.000532	0.000534	CcSEcCtD
Ibandronate—Rash—Gemcitabine—pancreatic cancer	0.000528	0.000529	CcSEcCtD
Ibandronate—Dermatitis—Gemcitabine—pancreatic cancer	0.000527	0.000529	CcSEcCtD
Ibandronate—Eye disorder—Epirubicin—pancreatic cancer	0.000527	0.000528	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000524	0.000526	CcSEcCtD
Ibandronate—Headache—Gemcitabine—pancreatic cancer	0.000524	0.000526	CcSEcCtD
Ibandronate—Cardiac disorder—Epirubicin—pancreatic cancer	0.000523	0.000525	CcSEcCtD
Ibandronate—Vomiting—Fluorouracil—pancreatic cancer	0.000523	0.000525	CcSEcCtD
Ibandronate—Dyspepsia—Docetaxel—pancreatic cancer	0.000523	0.000524	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000522	0.000523	CcSEcCtD
Ibandronate—Rash—Fluorouracil—pancreatic cancer	0.000519	0.00052	CcSEcCtD
Ibandronate—Dermatitis—Fluorouracil—pancreatic cancer	0.000518	0.00052	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—pancreatic cancer	0.000518	0.000519	CcSEcCtD
Ibandronate—Decreased appetite—Docetaxel—pancreatic cancer	0.000516	0.000518	CcSEcCtD
Ibandronate—Headache—Fluorouracil—pancreatic cancer	0.000516	0.000517	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000515	0.000517	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000514	0.000515	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000513	0.000514	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000513	0.000514	CcSEcCtD
Ibandronate—Fatigue—Docetaxel—pancreatic cancer	0.000512	0.000514	CcSEcCtD
Ibandronate—Angiopathy—Epirubicin—pancreatic cancer	0.000512	0.000513	CcSEcCtD
Ibandronate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000511	0.000513	CcSEcCtD
Ibandronate—Nausea—Irinotecan—pancreatic cancer	0.00051	0.000512	CcSEcCtD
Ibandronate—Immune system disorder—Epirubicin—pancreatic cancer	0.000509	0.000511	CcSEcCtD
Ibandronate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000508	0.00051	CcSEcCtD
Ibandronate—Constipation—Docetaxel—pancreatic cancer	0.000508	0.000509	CcSEcCtD
Ibandronate—Pain—Docetaxel—pancreatic cancer	0.000508	0.000509	CcSEcCtD
Ibandronate—Chills—Epirubicin—pancreatic cancer	0.000506	0.000507	CcSEcCtD
Ibandronate—Alopecia—Epirubicin—pancreatic cancer	0.000498	0.0005	CcSEcCtD
Ibandronate—Nausea—Gemcitabine—pancreatic cancer	0.000497	0.000499	CcSEcCtD
Ibandronate—Mental disorder—Epirubicin—pancreatic cancer	0.000494	0.000495	CcSEcCtD
Ibandronate—Malnutrition—Epirubicin—pancreatic cancer	0.000491	0.000492	CcSEcCtD
Ibandronate—Erythema—Epirubicin—pancreatic cancer	0.000491	0.000492	CcSEcCtD
Ibandronate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000489	0.000491	CcSEcCtD
Ibandronate—Nausea—Fluorouracil—pancreatic cancer	0.000489	0.00049	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—pancreatic cancer	0.000488	0.000489	CcSEcCtD
Ibandronate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000486	0.000487	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000484	0.000486	CcSEcCtD
Ibandronate—Flatulence—Epirubicin—pancreatic cancer	0.000484	0.000485	CcSEcCtD
Ibandronate—Dysgeusia—Epirubicin—pancreatic cancer	0.000481	0.000482	CcSEcCtD
Ibandronate—Back pain—Epirubicin—pancreatic cancer	0.000475	0.000476	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—pancreatic cancer	0.000473	0.000475	CcSEcCtD
Ibandronate—Muscle spasms—Epirubicin—pancreatic cancer	0.000472	0.000473	CcSEcCtD
Ibandronate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000471	0.000473	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00047	0.000472	CcSEcCtD
Ibandronate—Abdominal pain—Docetaxel—pancreatic cancer	0.00047	0.000471	CcSEcCtD
Ibandronate—Body temperature increased—Docetaxel—pancreatic cancer	0.00047	0.000471	CcSEcCtD
Ibandronate—Chills—Doxorubicin—pancreatic cancer	0.000468	0.000469	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—pancreatic cancer	0.000461	0.000462	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—pancreatic cancer	0.000457	0.000458	CcSEcCtD
Ibandronate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000455	0.000457	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—pancreatic cancer	0.000454	0.000455	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—pancreatic cancer	0.000454	0.000455	CcSEcCtD
Ibandronate—Anaemia—Epirubicin—pancreatic cancer	0.000454	0.000455	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—pancreatic cancer	0.000448	0.000449	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000445	0.000446	CcSEcCtD
Ibandronate—Malaise—Epirubicin—pancreatic cancer	0.000443	0.000444	CcSEcCtD
Ibandronate—Vertigo—Epirubicin—pancreatic cancer	0.000441	0.000442	CcSEcCtD
Ibandronate—Back pain—Doxorubicin—pancreatic cancer	0.000439	0.000441	CcSEcCtD
Ibandronate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000438	0.000439	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000437	0.000438	CcSEcCtD
Ibandronate—Palpitations—Epirubicin—pancreatic cancer	0.000434	0.000435	CcSEcCtD
Ibandronate—Asthenia—Docetaxel—pancreatic cancer	0.000426	0.000427	CcSEcCtD
Ibandronate—Hypertension—Epirubicin—pancreatic cancer	0.000424	0.000425	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000421	0.000423	CcSEcCtD
Ibandronate—Pruritus—Docetaxel—pancreatic cancer	0.00042	0.000421	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—pancreatic cancer	0.00042	0.000421	CcSEcCtD
Ibandronate—Myalgia—Epirubicin—pancreatic cancer	0.000418	0.000419	CcSEcCtD
Ibandronate—Chest pain—Epirubicin—pancreatic cancer	0.000418	0.000419	CcSEcCtD
Ibandronate—Arthralgia—Epirubicin—pancreatic cancer	0.000418	0.000419	CcSEcCtD
Ibandronate—Anxiety—Epirubicin—pancreatic cancer	0.000416	0.000418	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000415	0.000416	CcSEcCtD
Ibandronate—Discomfort—Epirubicin—pancreatic cancer	0.000413	0.000414	CcSEcCtD
Ibandronate—Malaise—Doxorubicin—pancreatic cancer	0.00041	0.000411	CcSEcCtD
Ibandronate—Dry mouth—Epirubicin—pancreatic cancer	0.000409	0.00041	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—pancreatic cancer	0.000408	0.000409	CcSEcCtD
Ibandronate—Diarrhoea—Docetaxel—pancreatic cancer	0.000406	0.000408	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—pancreatic cancer	0.000401	0.000403	CcSEcCtD
Ibandronate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000401	0.000402	CcSEcCtD
Ibandronate—Infection—Epirubicin—pancreatic cancer	0.000398	0.000399	CcSEcCtD
Ibandronate—Shock—Epirubicin—pancreatic cancer	0.000394	0.000395	CcSEcCtD
Ibandronate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000393	0.000394	CcSEcCtD
Ibandronate—Dizziness—Docetaxel—pancreatic cancer	0.000393	0.000394	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—pancreatic cancer	0.000392	0.000393	CcSEcCtD
Ibandronate—Skin disorder—Epirubicin—pancreatic cancer	0.000389	0.00039	CcSEcCtD
Ibandronate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000387	0.000388	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—pancreatic cancer	0.000387	0.000388	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—pancreatic cancer	0.000387	0.000388	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—pancreatic cancer	0.000387	0.000388	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—pancreatic cancer	0.000385	0.000386	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000384	0.000385	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—pancreatic cancer	0.000382	0.000383	CcSEcCtD
Ibandronate—Dry mouth—Doxorubicin—pancreatic cancer	0.000378	0.000379	CcSEcCtD
Ibandronate—Vomiting—Docetaxel—pancreatic cancer	0.000378	0.000379	CcSEcCtD
Ibandronate—Rash—Docetaxel—pancreatic cancer	0.000375	0.000376	CcSEcCtD
Ibandronate—Dermatitis—Docetaxel—pancreatic cancer	0.000374	0.000375	CcSEcCtD
Ibandronate—Headache—Docetaxel—pancreatic cancer	0.000372	0.000373	CcSEcCtD
Ibandronate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000371	0.000372	CcSEcCtD
Ibandronate—Infection—Doxorubicin—pancreatic cancer	0.000368	0.000369	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000365	0.000366	CcSEcCtD
Ibandronate—Shock—Doxorubicin—pancreatic cancer	0.000365	0.000366	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000364	0.000365	CcSEcCtD
Ibandronate—Insomnia—Epirubicin—pancreatic cancer	0.000362	0.000363	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—pancreatic cancer	0.00036	0.000361	CcSEcCtD
Ibandronate—Paraesthesia—Epirubicin—pancreatic cancer	0.00036	0.000361	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000358	0.000359	CcSEcCtD
Ibandronate—Nausea—Docetaxel—pancreatic cancer	0.000353	0.000354	CcSEcCtD
Ibandronate—Dyspepsia—Epirubicin—pancreatic cancer	0.000353	0.000354	CcSEcCtD
Ibandronate—Decreased appetite—Epirubicin—pancreatic cancer	0.000348	0.000349	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000346	0.000347	CcSEcCtD
Ibandronate—Fatigue—Epirubicin—pancreatic cancer	0.000345	0.000346	CcSEcCtD
Ibandronate—Pain—Epirubicin—pancreatic cancer	0.000343	0.000344	CcSEcCtD
Ibandronate—Constipation—Epirubicin—pancreatic cancer	0.000343	0.000344	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000338	0.000339	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—pancreatic cancer	0.000335	0.000336	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000333	0.000334	CcSEcCtD
Ibandronate—Feeling abnormal—Epirubicin—pancreatic cancer	0.00033	0.000331	CcSEcCtD
Ibandronate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000328	0.000329	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000326	0.000327	CcSEcCtD
Ibandronate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000322	0.000323	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00032	0.000321	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—pancreatic cancer	0.00032	0.00032	CcSEcCtD
Ibandronate—Urticaria—Epirubicin—pancreatic cancer	0.000318	0.000319	CcSEcCtD
Ibandronate—Pain—Doxorubicin—pancreatic cancer	0.000317	0.000318	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—pancreatic cancer	0.000317	0.000318	CcSEcCtD
Ibandronate—Abdominal pain—Epirubicin—pancreatic cancer	0.000317	0.000318	CcSEcCtD
Ibandronate—Body temperature increased—Epirubicin—pancreatic cancer	0.000317	0.000318	CcSEcCtD
Ibandronate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000305	0.000306	CcSEcCtD
Ibandronate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000303	0.000304	CcSEcCtD
Ibandronate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000295	0.000296	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—pancreatic cancer	0.000294	0.000295	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000293	0.000294	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000293	0.000294	CcSEcCtD
Ibandronate—Asthenia—Epirubicin—pancreatic cancer	0.000287	0.000288	CcSEcCtD
Ibandronate—Pruritus—Epirubicin—pancreatic cancer	0.000283	0.000284	CcSEcCtD
Ibandronate—Diarrhoea—Epirubicin—pancreatic cancer	0.000274	0.000275	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000273	0.000274	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—pancreatic cancer	0.000266	0.000267	CcSEcCtD
Ibandronate—Dizziness—Epirubicin—pancreatic cancer	0.000265	0.000266	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—pancreatic cancer	0.000262	0.000263	CcSEcCtD
Ibandronate—Vomiting—Epirubicin—pancreatic cancer	0.000255	0.000255	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000254	0.000254	CcSEcCtD
Ibandronate—Rash—Epirubicin—pancreatic cancer	0.000253	0.000253	CcSEcCtD
Ibandronate—Dermatitis—Epirubicin—pancreatic cancer	0.000252	0.000253	CcSEcCtD
Ibandronate—Headache—Epirubicin—pancreatic cancer	0.000251	0.000252	CcSEcCtD
Ibandronate—Dizziness—Doxorubicin—pancreatic cancer	0.000245	0.000246	CcSEcCtD
Ibandronate—Nausea—Epirubicin—pancreatic cancer	0.000238	0.000239	CcSEcCtD
Ibandronate—Vomiting—Doxorubicin—pancreatic cancer	0.000236	0.000236	CcSEcCtD
Ibandronate—Rash—Doxorubicin—pancreatic cancer	0.000234	0.000234	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—pancreatic cancer	0.000234	0.000234	CcSEcCtD
Ibandronate—Headache—Doxorubicin—pancreatic cancer	0.000232	0.000233	CcSEcCtD
Ibandronate—Nausea—Doxorubicin—pancreatic cancer	0.00022	0.000221	CcSEcCtD
